Literature DB >> 8609334

Coronary flow velocity changes after intravenous dipyridamole infusion: measurements using intravascular Doppler guide wire. A documentation of flow inhomogeneity.

V Voudris1, A Manginas, V Vassilikos, M Koutelou, J Kantzis, D V Cokkinos.   

Abstract

OBJECTIVES: This study assessed changes in coronary flow velocity measured distal to a significant stenosis of the left anterior descending coronary artery and at the adjacent normal left circumflex coronary artery, produced by intravenous administration of dipyridamole, in patients undergoing coronary angioplasty with a documented perfusion defect on dipyridamole-thallium-201 scintigraphy.
BACKGROUND: Significant flow inhomogeneity is believed to develop during coronary vasodilation induced by dipyridamole, causing a defect in the thallium-201 scintigram. The recently developed intracoronary Doppler guide wire permits assessment of flow velocity variables in normal and stenotic arteries.
METHODS: In 17 patients with stable angina we studied changes in time-averaged peak velocity and the diastolic/systolic velocity ratio simultaneously using two 0.014-in. (0.36-mm) Doppler guide wires at baseline and after 4 min of dipyridamole infusion (0.56 mg/kg body weight). Coronary flow velocity reserve and relative flow reserve were correlated with the degree of stenosis on coronary angiography and quantitative analysis of thallium-201 images.
RESULTS: No changes in distal flow velocity was observed in the stenotic vessel (5.5 +/- 33.7% [mean +/- SD]), in contrast to a significant increase observed in the adjacent normal vessel (162.4 +/- 39.8%). Poststenotic coronary flow velocity reserve correlated with percent lumen diameter stenosis (r = -0.66, p < 0.05). A correlation was also observed between the relative flow reserve/thallium-201 relative perfusion ratio (r = 0.90, p < 0.001).
CONCLUSIONS: To our knowledge, these findings represent the first direct proof of dipyridamole-induced flow inhomogeneity producing a perfusion defect on thallium-201 imaging. The degree of inhomogeneity is related to the extent of the perfusion defect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609334     DOI: 10.1016/0735-1097(95)00569-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Coronary flow: clinical considerations.

Authors:  D V Cokkinos; A Manginas; V Voudris
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

2.  MR-based coronary artery blood velocity measurements in patients without coronary artery disease.

Authors:  M Schiemann; F Bakhtiary; V Hietschold; A Koch; A Esmaeili; H Ackermann; A Moritz; T J Vogl; N D Abolmaali
Journal:  Eur Radiol       Date:  2006-01-13       Impact factor: 5.315

3.  Assessment of the severity of coronary artery stenosis by the ratio of the regional washout rate determined by adenosine triphosphate stress Tl-201 SPECT.

Authors:  H Teragawa; T Yamagata; M Kato; M Hiraga; H Matsuura; G Kajiyama
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

4.  Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve: a report from the WISE-CVD study.

Authors:  Seong-Mi Park; Janet Wei; Galen Cook-Wiens; Michael D Nelson; Louise Thomson; Daniel Berman; Eileen Handberg; John Petersen; David Anderson; Carl J Pepine; C Noel Bairey Merz
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-08-01       Impact factor: 6.875

5.  Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study.

Authors:  Kamran Shaikh; Dee Dee Wang; Hani Saad; Mohsin Alam; Akshay Khandelwal; Kristen Brooks; Hari Iyer; Phuc Nguyen; Stephanie Boedeker; Karthik Ananthasubramaniam
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-25       Impact factor: 2.357

6.  Inotropic stress with arbutamine is superior to vasodilator stress with dipyridamole for the detection of reversible ischemia with Tc-99m sestamibi single-photon emission computed tomography.

Authors:  P Soman; R Khattar; R Senior; A Lahiri
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

Review 7.  Beta-blockers and coronary flow reserve: the importance of a vasodilatory action.

Authors:  Maurizio Galderisi; Arcangelo D'Errico
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.

Authors:  Mara Boschetti; Sergio Agosti; Valeria Albanese; Laura Casalino; Claudia Teti; Gian Paolo Bezante; Claudio Brunelli; Manuela Albertelli; Diego Ferone
Journal:  Endocrine       Date:  2016-04-13       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.